Carbetocin

Carbetocin
Product Description

Carbetocin indicated for the prevention of uterine atony following delivery of the infant by caesarean section under epidural or spinal anaesthesiaForm & strength: 100 mcg/ ml solution for injection

PharmIdea

  • LV
  • 2015
    On CPHI since
  • 1
    Certificates
  • 50 - 99
    Employees
Company types
Contract Service
Manufacturer/Innovator
Specifications

PharmIdea

  • LV
  • 2015
    On CPHI since
  • 1
    Certificates
  • 50 - 99
    Employees
Company types
Contract Service
Manufacturer/Innovator

More Products from PharmIdea (4)

  • Levosimendan

    Product Levosimendan

    Levosimendan indicated for short-term treatment of acutely decompensated severe chronic heart failure. Form & strength: 2.5mg/ml concentrate for solution for infusion 

  • Caspofungin

    Product Caspofungin

    Caspofungin  powder for concentrate for solution for infusion
    50mg/vial
    70mg/vial
    Caspofungin is a new class of echinocandin antifungal agent with broad spectrum of activity used to treat a variety of fungal infections.

  • Atosiban

    Product Atosiban

    Atosiban indicated to delay imminent pre-term birth in pregnant adult women.Form & strength: 6.75 mg/ 0.9ml solution for injection and 37.5mg/ 5 ml concentrate for solution for infusion
  • Dexmedetomidine

    Product Dexmedetomidine

    Dexmedetomidine is indicated:1. for sedation of adult Intensive Care Unit patients requiring a sedation level not deeper than arousal in response to verbal stimulation
    2. for sedation of non-intubated adult patients prior to and/or during diagnostic or surgical procedures requiring sedation, i.e. proc...

PharmIdea resources (1)

  • News New products for Out-Licensing

    Pharmidea offers completed CTD for Out-Licensing and contract manufacturing of Levosimendan 2.5mg/ ml concentrate for solution for infusion in small batch size, produced at EU GMP approved manufacturing site located in Latvia.